Market capitalization of biopharmaceutical companies exceeds KRW 1 trillion
It was observed the average R&D investment ratio of listed biopharmaceutical companies to sales exceeded 20%.
The phenomenon seems biopharmaceutical ventures have to spend an enormous amount of R&D expenses, but have relatively weaker structures externally.
In fact, there were approximately 5 b...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
